ASDIN 7th Annual Scientific Meeting
|
|
- Clifton Hunt
- 5 years ago
- Views:
Transcription
1 Strategies for Decreasing the Use of Hemodialysis Catheters ASDIN 7 th Annual Scientific Meeting Outline Late referral Primary failure Why Not PD? Summary Micah Chan MD MPH FACP Assistant Professor of Medicine University of Wisconsin School of Medicine and Public Health CVCs first described by Teschan in 1959 as a form of hemodialysis access TDCs developed d in 8s as an alternative ti to temporary catheters Despite significant innovations along the way, after 5 years clinicians still remain dependant on an access modality that is universally regarded as inadequate Lacson et al AJKD 27: 5 The USRDS reported that catheters have the highest overall cost per person per year in 26 with $77,93 in expenditures; a large proportion of this cost is due to catheter-related infection Despite these well described complications, according to the ESRD Networks, 21% of prevalent HD patients were dialyzing with a CVC for 9 days or longer. This is far greater than the NKF K/DOQI published recommendations of less than 1% CVC prevalence RR of death associated with catheter use as compared to AVF is 1.4 to 3.4 fold greater Dhingra and collegues in 21, using the USRDS Dialysis Morbidity and Mortality Study Wave 1 (DMMS), did the first national study on vascular access in 5 prevalent dialysis patients from 55 dialysis units across the U.S. In both diabetic and non-diabetic ESRD patients, the adjusted relative risk of death was 79% and 8% higher in the TDC group as compared to the AVF group respectively on two-year follow-up. Subsequent reports uphold the evidence that TDCs are associated with a 4-7% increased risk of death as compared to autogenous AVF in the K/DOQI era 1
2 Adjusted Relative Risk of Death by Vascular Access Type Among Non-Diabetic Patients 2 2 Adjusted Relative Risk of Death by Vascular Access Type Among Diabetic Patients 1.91 ortality Risk Relative Mo p< p<.35 ref p<..55 p<.65 ref ortality Risk Relative Mo p<.2 p<.3 1. ref p< p< ref CVC AVG AVF CVC AVG AVF Prevalent Incident CVC AVG AVF CVC AVG AVF Prevalent Incident Dhingra et al. Type of vascular access and mortality in U.S. HD patients. KI Oct 21 Dhingra et al. Type of vascular access and mortality in U.S. HD patients. KI Oct 21 Fistula First Breakthrough Initiative This seminal study was the impetus for the 26 KDOQI updated guidelines on vascular access FFBI was a coalition sponsored by the Centers for Medicare and Medicaid Services (CMS) that launched in 24 It met its 4% prevalence goal by 26, a year early Subsequently, due to its success, stipulated a 66% fistula rate ents % of Patie Percent of Incident Patients with AV Fistula 51 42% US Network ents % of Patie Percent of Prevalent Patients with Catheter 27% US Network ents % of Pati Percent of Prevalent Patients with Catheter > 9 days 28 21% US Network 2
3 Astor, et al showed that patients with delayed referral to nephrologists prior to initiation of dialysis, were more likely to initiate with a chronic catheter and use one for longer periods of time compared to timely referral. They subsequently showed increased mortality risks directly attributable to this delayed timing of nephrologist referral. USRDS reported that in 27 among incident hemodialysis patients mortality peaked in the second and third month after initiation of dialysis and that in the first month of initiation, hospital admissions for infection were twice as high as in months 1-12 Astor BC, et al. AJKD 21; 38 Chan MR, et al. Am J Med 27;12 Figure 1. Graph from 26 ESRD CPM Project 5 (Fig. 3, p 36) shows percent of incident* adult in-center hemodialysis patients with different types of vascular access 9 days after initiation of dialysis 57% USRDS 29 I. KDOQI CLINICAL PRACTICE GUIDELINES FOR VASCULAR ACCESS GUIDELINE 1. PATIENT PREPARATION FOR PERMANENT HEMODIALYSIS ACCESS Appropriate planning allows for the initiation of dialysis therapy at the appropriate time with a permanent access in place at the start of dialysis therapy. 1.3 Patients should have a functional permanent access at the initiation of dialysis therapy A fistula should be placed at least 6 months before the anticipated start of HD treatments. This timing allows for access evaluation and additional time for revision to ensure a working fistula is available at initiation of dialysis therapy. (B) Education for PCP on egfr referral based protocols Multidisciplinary team engaged g to: educate on modality selection vessel mapping surgical evaluation CQI reviews monitoring and surveillance What is a trigger for referral? egfr 2-25ml/min/1.73m225ml/min/1.73m2 Rapid egfr decline 1/creat slope At least 4-8months from referral to initiation 4-8wk lag from referral to first visit to neph clinic 4-8wk lag from first neph visit to surgical appt 2-4wk lag from surgical appt to AVF 6-12wk lag from surgery to AVF use Lenz Asif, Semin Dial 26: 19 Lacson et al AJKD27: 5 3
4 The Multidisciplinary Team The Multidisciplinary Team ESRD Network 7 conducted a study called gap-reduction assisted catheter elimination (GRACE) strategy Goal was a gap reduction of 5% from the baseline catheter rate of the given facility when compared with the Network 7 mean facility catheter rate and the sustainability of catheter reduction for at least 3 consecutive months 15 facilities with high catheter rates (>25%) were included in the study with n=891 Multidisciplinary team approach Focused vascular access education for medical staff Complications Types Vascular mapping techniques Early referral for primary failure Monthly catheter tracking Regular conference calls and site visits The preintervention catheter rate in these facilities was 31.5± 5.3%. Application of interventions resulted in catheter reduction to ± 8.5% in May 27 (p =.1) 1) Medical director s involvement had a positive impact in achieving the goal (p =.3). Kulawik Asif, Semin Dial 29: 22 Kulawik Asif, Semin Dial 29: 22 Vascular education and mapping Prospective study of 86 patients with TDCs showed with vascular mapping that 94% (64/66) with no prior arteriovenous access had suitable veins for access placement 9% with previously failed arteriovenous access (18/2) also had suitable veins AVF were made in 94% of those that agreed to surgery (68/72) Catheter use significantly decreased from 34 to 14% Primary Failure: The Challenge Radiocephalic (Brescia-Cimino) 85% 1-year patency 1-3% primary failure rate Asif et al. KI 25;67:2399 Primary Failure: The Challenge Brachiocephalic 75% 1-year patency 2-3% primary failure rate Primary Failure: The Challenge Brachiobasilic (transposition) 77% 1-year patency 1-4% primary failure rate 4
5 Primary Failure: Reasons Whether it is a primary or secondary access (after >=1 failed) Blood vessel selection Experience of surgeon Patient care staff education and early cannulation Primary Failure: Solutions Tessitore et al showed in a 5-year RCT in 79 pts that preemptive treatment reduced failure rate (P=.3) and resulted in longer primary patency (p=.21) -NDT 24;19:2325 Subsequently Polinghorne et al demonstrated in a RCT of 137 pts that Qa surveillance detects significant stenoses NDT 26;21:2498 Beathard demonstrated in a prospective observational study of 1 pts successful salvage of primary failure KI 23;64:1487 Primary Failure: Solutions Primary Failure: Solutions Success rate of angioplasty of 98% and vein obliteration of 1% After intervention, possible to initiate dialysis with AVF in 92% cases Beathard KI 23;64:1487 Lok CE, et al JASN 26:17 Why Not PD? Surveys of practicing nephrologists believe the optimal ratio of HD to PD would be 65:35 in Canada and U.S. 6:4 in the UK (Am J Kidney Dis. 21 Jan;37(1):22-29.) When asked what they would do if were on dialysis, 98% of medical directors would do a home-based therapy ( If the PD share of total dialysis were to decrease from current 8% to 5%, Medicare spending for dialysis would increase by an additional $41 million over a 5-year period. Alternatively, if the PD share of total dialysis were to increase to 15%, Medicare could realize a savings of >$1.1 billion over 5 years. (Clin Ther. 29 Apr;31(4):88-8) 8) Comparison of HD with CVC to PD Starting HD with CVC Inadequate HD when compared to AVF and AVG CVC induced central vein stenosis and thrombosis poses a threat to successful AVF and AVG placement A very high incidence of catheter-associated associated blood stream infections resulting in a high mortality Starting with PD Preserve vascular access sites Bridge therapy to HD Equal or better survival in the first 2 years of dialysis Preservation of residual renal function Greater patient satisfaction Infections are fewer & milder Financial superiority Courtesy of K. Abreo 5
6 PDC Infections Same as AVF! Can PD be Initiated in the Late-Referred ESRD Patient (no vascular access or immature AVF)? PC AVF PD HR 95%CI PC TC AVG AVF 1 Ref PD patients with ESRD started on 12-hour APD Coiled, double-cuffed Tenkhoff catheters inserted by open surgery under local anesthesia and without the use of prophylactic antibiotics Exceptionally good surgical support 7 days a week Standard prescription for acute APD was: 12h overnight, total volume 1L with maximum dwell volume 1.2L (BW<6 Kg) or 14L with maximum dwell volume 1.5L (BW>6Kg), tidal volume 5-75% Supine at night, free to walk during dry day Ishani et al, KI 68:311, 25 Courtesy of K. Abreo Povlsen & Ivarson, NDT 26 Comparison of Acute and Planned PD Increase in PD Patients When Nephrologists Place Catheters Acute Planned P 52(%) 52(%) Infectious complications 1 (19.2) 11 (21.2) NS Mechanical complications 15 (28.9) 4 (7.7) <.1 Surgical replacement 1 (19.2) 2 (3.9) <.2 2 PD technique survival at 3 mo. 39/52 (75) 45/52 (86.5) NS PD technique survival, censored for death & transplantation 39/45 (86.7) 45/5 (9) NS Povlsen & Ivarson, NDT 26 Asif et al, Seminars in Dialysis 18: 157, 25 Why Not PD? Why Not PD? It is important to note that there has never been a robust randomized controlled trial comparing HD vs PD. The only trial to design and implement an RCT was from the Netherlands. They screened 735 eligible patients from the NECOSAD cohort but only 38 patients agreed to randomization. (Kidney International, Vol. 64 (23), pp. 2222) Indeed, when fully educated and given a free choice, approximately 5% pts choose PD. Recent study showed that among patients with CKD stage 5, 96% had knowledge of HD and only 78% had knowledge of PD. (Kidney Int. 28 Nov;74(9):.) Most recent study of cohort of 98,875 adults who initiated dialysis in 23 showed cumulative survival was higher for peritoneal dialysis patients than for hemodialysis patients (hazard ratio.92; 95% CI.86 to 1., P =.4) followed up to 5 years. (JASN 21:21;499) PD has many advantages over HD with a CVC in the early months of dialysis: Decreased infection-related mortality and preservation of veins for vascular access PD offers improved survival after transplant Patient and physician education play an important role in promoting PD as the best early dialysis modality PD catheter embedding technique would allow placement of the catheter in CKD4 The PD population grows in centers where Interventional Nephrologists are actively involved in catheter placement Back-up AVF in PD patients allows for a smooth transition to HD without CVC placement 6
7 Summary Points Adopt a Catheter Last program Nephrologist must take the lead and gain appropriate buy in from staff, surgeons, interventionalists, hospital Multidisciplinary team to educate patients, staff and physicians Review the evidence and best practices Establish algorithms and routine CQI program Early referral process with egfr based protocols and PCP education Monitoring and surveillance Early salvage PD as a bridge to AVF 7
ASDIN 8th Annual Scientific Meeting
Fistula First Breakthrough Initiative Fistula First Breakthrough Initiative Marianne Neumann, RN, CNN FFBI Clinical Lead New Orleans, LA February 26, 2012 Initiated in 2003 by CMS, Goals Include: to ensure
More informationTechnical and Clinical Barriers to Implementing an Optimal Case Mix of Vascular Access
Technical and Clinical Barriers to Implementing an Optimal Case Mix of Vascular Access Louise Moist Associate Professor Lead Vascular Access Ontario Renal Network Schulich School of Medicine University
More informationSid Bhende MD Sentara Vascular Specialists April 28 th Dialysis Access Review: Understanding the Access Options our Patients Face
Sid Bhende MD Sentara Vascular Specialists April 28 th 2018 Dialysis Access Review: Understanding the Access Options our Patients Face Disclosures Dialysis Background Why is it important? Outline National
More informationPreservation of Veins and Timing for Vascular Access
Preservation of Veins and Timing for Vascular Access Vassilis Liakopoulos, MD, PhD Department of Nephrology School of Medicine University of Thessaly Greece Hemodialysis VA A sound long-term dialysis access
More informationBackground. Background. Background. Curriculum Design and Editorial Process. Creating a PD Curriculum. ASDIN HVA Core Curriculum
Background Creating a PD Curriculum Steven Wu, MD Director of Interventional Nephrology Massachusetts General Hospital Harvard Medical School The scope of our current practice as a new subspecialty within
More informationMedical Director/Surgeon as Partners WebEx February 11, 2010
Medical Director/Surgeon as Partners WebEx February 11, 2010 Over 400,000 patients are treated yearly for ESRD in the USA; 60% of these patients receive some form of hemodialysis Despite major advances
More informationVascular Access Care Plans: How Can a Care Plan Really Improve Care and Make Everyone s Job Easier?
Vascular Access Care Plans: How Can a Care Plan Really Improve Care and Make Everyone s Job Easier? Plan the Work Work the Plan What is a plan? A method for achieving an end An orderly arrangement of parts
More informationDisclosures. History. Case. Using the peritoneal cavity for dialysis. Background 2/4/2015 ASDIN PD in the Acute Setting- Myth or Reality?
PD in the Acute Setting- Myth or Reality? ASDIN Scientific Meeting February 15, 2015 Disclosures Investigator: BARD, Otsuka, Shire, Gilead Grants: Amgen Consultant: Covidien, Deltanoid No disclosures for
More informationThe vexing problem of suboptimal initiation of dialysis: Can we do better?
Budapest Nephrology School August 30, 2010 The vexing problem of suboptimal initiation of dialysis: Can we do better? David C Mendelssohn Disclosures 2007 2010 Speaker Fees: Amgen, Ortho Biotech, Genzyme,
More informationChapter Five Clinical indicators & preventive health
Chapter Five Clinical indicators & preventive health The painter who draws merely by practice and by eye, without any reason, is like a mirror which copies every thing placed in front of it without being
More informationIncident Hemodialysis
The Acute Kidney Injury Group Modifying the Highest Mortality Rate in the Major AKI Adverse Outcome Other than Death: Loss ESRD & Incident Hemodialysis The EVA QI Program Integrated Inpatient Early Vascular
More informationLesson #7: Quality Assessment and Performance Improvement
ESRD Update: Transitioning to New ESRD Conditions for Coverage Student Manual Lesson #7: Quality Assessment and Performance Improvement Learning Objectives At the conclusion of this lesson, you will be
More informationVascular Access creation in the US A surgical perspective. Surendra Shenoy M.D., Ph.D. Section of Transplantation Department of Surgery
Vascular Access creation in the US A surgical perspective Surendra Shenoy M.D., Ph.D. Section of Transplantation Department of Surgery Disclosures No specific disclosures pertaining to the topic of presentation
More informationEnd Stage Renal Disease (ESRD) Network Learning and Action Network (LAN) Series: Bloodstream Infection (BSI) Quality Improvement Activity
End Stage Renal Disease (ESRD) Network Learning and Action Network (LAN) Series: Bloodstream Infection (BSI) Quality Improvement Activity October 2, 2018 Note: Computer speakers or headphones are necessary
More informationClinical Performance Measures for ESRD Patients. Lana Kacherova, QI Director, ESRD Network th Annual NANT Symposium February 12, 2009
Clinical Performance Measures for ESRD Patients Lana Kacherova, QI Director, ESRD Network 18 26 th Annual NANT Symposium February 12, 2009 Health Care Quality Improvement Program (HCQIP) The Center for
More informationDeveloping a Quality Assurance Performance Improvement (QAPI) Program at Your Dialysis Center Rudolph P. Valentini, M.D. Associate Professor of Pediatrics Director of Dialysis Services Vice Chief of Staff
More informationVascular a ccess access for Dialysis a surgeon s perspecti e v. some observations
Vascular access for Dialysis a surgeon s perspective e. some observations Age of New Haemodialysis Patients 2005 Australia Number (Total=1957) 0.7% 3% 5% 10% 15% 20% 26% 19% 2% 0-14 15-24 25-34 35-44
More informationmorbidity & mortality
morbidity & mortality esrd introduction of ESRD treatment. We examine these concerns throughout the ADR, particularly in Chapter One. This year we focus on infectious complications, especially those related
More informationWhy Can't I Cannulate This Fistula? Fistula Immaturity: The Simple But Critical Steps for a Functioning (Mature) AVF
Why Can t I Cannulate This Access? Steven J. Bander M.D. Adjunct Professor of Nephrology St. Louis University Director, Vascular Access Center, St. Luke s Hospital Saint Louis, MO Why Can't I Cannulate
More informationDialysis Initiation and Optimal Vascular Access: Outcomes and Mortality
Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality Shannon H. Norris, BSN, RN June 6, 2018 Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality DISCUSSION: End Stage
More informationDecreased Incidence of Clotted AV Access in Hemodialysis Patients after the Implementation of Follow up Program
Global Journal of Health Science; Vol. 8, No. 10; 2016 ISSN 1916-9736 E-ISSN 1916-9744 Published by Canadian Center of Science and Education Decreased Incidence of Clotted AV Access in Hemodialysis Patients
More informationCATHETER REDUCTION. Angelo N. Makris, M.D. Medical Director Chicago Access Care
CATHETER REDUCTION Angelo N. Makris, M.D. Medical Director Chicago Access Care Objectives Discuss tools/techniques proven to improve AVF rates & decrease catheter rates Implement a change process in your
More informationUtopia Health Career Center, LLC. Do not distribute without permission.
Introduction What is dialysis and a brief history. What laws govern dialysis treatments. How to ensure high quality care for patients. How to behave in a professional way. How to become certified. We don
More informationQuality ID #329: Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis National Quality Strategy Domain: Effective Clinical Care
Quality ID #329: Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE:
More informationMeasure #329: Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis National Quality Strategy Domain: Effective Clinical Care
Measure #329: Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES REGISTRY ONLY This is
More informationUPDATE IN VASCULAR ACCESS Mercedeh Kiaii MD FRCPC Rick Luscombe RN BSN CNeph(C) Elizabeth Lee MD FRCPC
UPDATE IN VASCULAR ACCESS Mercedeh Kiaii MD FRCPC Rick Luscombe RN BSN CNeph(C) Elizabeth Lee MD FRCPC Background Endovascular AVF Outline Data from FLEX and NEAT study SPH data Clinical experience Cannulation
More informationDifference in practical dialysis therapy between East Asia and US/EU
Difference in practical dialysis therapy between East Asia and US/EU Jer-Ming Chang. M.D., Ph.D. 1 Professor, Attending physician, Kaohsiung Medical University Hospital; 2 Secretary General, Taiwan Society
More informationJVA ISSN Hemodialysis vascular access management in the Netherlands. Introduction ORIGINAL ARTICLE
JVA ISSN 1129-7298 J Vasc Access 2015; 16 (Suppl 9): S11-S15 DOI: 10.5301/jva.5000366 ORIGINAL ARTICLE Hemodialysis vascular access management in the Netherlands Jan H.M. Tordoir 1, Magda M. van Loon 1,
More informationJuxta-anastomotic stenoses: angioplasty or surgery (or when/why should we wait)?
Juxta-anastomotic stenoses: angioplasty or surgery (or when/why should we wait)? Richard Shoenfeld MD, FSIR, FAHA The Access Center at West Orange West Orange, New Jersey USA SEDAV 2015 Madrid November
More informationRenal Physicians Association Kidney Quality Improvement Registry, Powered by Premier, Inc non-mips Measure Specifications
Renal Physicians Association Kidney Quality Improvement Registry, Powered by Premier, Inc. 2018 non-mips Measure Specifications Last updated January 2, 2018 RPAQIR1: Angiotensin Converting Enzyme (ACE)
More informationNarender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York
Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York 4th International Conference on Nephrology & Therapeutics September 14, 2015 Baltimore,
More informationMIHÁLY TAPOLYAI, MD, FASN, FACP Associate Professor, Louisiana State University; Shreveport, Louisiana, USA Associate Professor; University of Hawai
MIHÁLY TAPOLYAI, MD, FASN, FACP Associate Professor, Louisiana State University; Shreveport, Louisiana, USA Associate Professor; University of Hawai i Postgraduate Training Program at Chubu Hospital, Okinawa,
More informationGerald Beathard Annual State of the Art Lecture Innovations in Vascular Access - Have We Moved Forward?
Gerald Beathard Annual State of the Art Lecture Innovations in Vascular Access - Have We Moved Forward? Maurizio Gallieni Nephrology and Dialysis Unit Ospedale S. Carlo Borromeo, ASST Santi Paolo e Carlo,
More informationIntroduction to the Native Arteriovenous Fistula: A primer for medical students and radiology residents
Introduction to the Native Arteriovenous Fistula: A primer for medical students and radiology residents Jesus Contreras, D.O. PGY-4 John Yasmer, D.O. Department of Radiology No Disclosures Objectives Introduce
More informationIl paziente anziano, evidenza e survey nazionale
Università La Sapienza Scuola di Specializzazione in Nefrologia Prof P. Menè Meeting di Nefrololgia Interventistica L Accesso Vascolare Impossibile Roma 23 Marzo 2016 Il paziente anziano, evidenza e survey
More informationInnovation in Technology II: Changed and Improved Design. PD Catheters- designs. Bharat Sachdeva MD LSU Shreveport
Innovation in Technology II: Changed and Improved Design PD Catheters- designs Bharat Sachdeva MD LSU Shreveport What s at risk? Why Is Material/Design Important? Reduce risk for transfer to HD Displacement
More informationCardiovascular Implantable Electronic Device Leads & Arteriovenous Hemodialysis Access
Cardiovascular Implantable Electronic Device Leads & Arteriovenous Hemodialysis Access Theodore F. Saad, MD Nephrology Associates, PA Christiana Care Health System Newark, Delaware Cardiovascular Implantable
More informationSelection of Permanent Hemodialysis Vascular Access
Selection of Permanent Hemodialysis Vascular Access TABLE OF CONTENTS 1.0 Scope...1 2.0 Recommendations & Rationale... 2 3.0 References... 3 4.0 Sponsors... 9 5.0 Effective Date... 10 Appendix 1: Key Elements
More informationUC SF. End Stage Renal Disease. National Kidney Foundation Dialysis Outcomes Quality Initiative (K/DOQI) BUT-- No Cephalic Vein What s Next
No Cephalic Vein What s Next End Stage Renal Disease Charles Eichler MD Clinical Professor of Surgery Division of Vascular Surgery UCSF April 5, 2014 Population of patients with ESRD growing rapidly -
More informationKDOQI Guidelines. Overview. Predicting Successful Fistula Maturation Warren Gasper MD UCSF Vascular Surgery Fellow 2011 UCSF Vascular Symposium
DISCLOSURES: NONE Predicting Successful Fistula Maturation Warren Gasper MD UCSF Vascular Surgery Fellow 2011 UCSF Vascular Symposium KDOQI Guidelines AV fistulas have better outcomes than grafts or catheters
More informationIN.PACT AV Access IDE Study Full Baseline Data. Robert Lookstein, MD MHCDL New York, NY On Behalf of the IN.PACT AV ACCESS Investigators
IN.PACT AV Access IDE Study Full Baseline Data Robert Lookstein, MD MHCDL New York, NY On Behalf of the IN.PACT AV ACCESS Investigators Disclosures Speaker name: Robert Lookstein, MD... I have the following
More informationFULFILLMENT OF K/DOQI GUIDELINES 92 anemia treatment dialysis therapy vascular access
INTRODUCTION ANEMIA TREATMENT hemoglobin levels epo treatment iron treatment FULFILLMENT OF K/DOQI GUIDELINES 2 anemia treatment dialysis therapy vascular access EPO DOSING PATTERNS 4 epo dosing per kg
More informationYou can sleep while I dialyze
You can sleep while I dialyze Nocturnal Peritoneal Dialysis Dr. Suneet Singh Medical Director, PD, VGH Division of Nephrology University of British Columbia Acknowledgements Melissa Etheridge You can sleep
More informationDr. Murty Mantha MD FRACP Cairns Base Hospital Cairns. DNT 2011 Hunter Valley
Dr. Murty Mantha MD FRACP Cairns Base Hospital Cairns DNT 2011 Hunter Valley Approximately 45% of AVF are functional without intervention after creation The procedure rate is 1.45-3.3 procedures/avf
More informationWhat s on the Horizon in Dialysis Access? Libby Watch, MD, FACS Miami Cardiac & Vascular Institute
What s on the Horizon in Dialysis Access? Libby Watch, MD, FACS Miami Cardiac & Vascular Institute Disclosures No relevant disclosures Employee Advanced Access Care Dialysis Work 5 operating surgeons 3
More information7/7/2015. Objectives. Pros and Cons of Buttonhole Cannulation
Objectives Pros and Cons of Buttonhole Cannulation Charmaine Lok, MD, FRCPC, MSc University of Toronto Toronto General Hospital To gain an appreciation of the importance of proper vascular access cannulation
More informationStatus of the CKD and ESRD treatment: Growth, Care, Disparities
Status of the CKD and ESRD treatment: Growth, Care, Disparities United States Renal Data System Coordinating Center An J. Collins, MD FACP Director USRDS Coordinating Center Robert Foley, MB Co-investigator
More informationWhat Happened? 3/20/2017. Changing Lives and Making a Difference: Home Hemodialysis Stories. Brigitte Schiller, MD, FACP, FASN
Changing Lives and Making a Difference: Home Hemodialysis Stories Brigitte Schiller, MD, FACP, FASN Chief Medical Officer Satellite Healthcare What Happened? We started building centers We started peritoneal
More informationAJNT. Original Article
. 2012 May;5(2):81-6 Original Article AJNT Reaching Target Hemoglobin Level and Having a Functioning Arteriovenous Fistula Significantly Improve One Year Survival in Twice Weekly Hemodialysis Sarra Elamin
More information02/27/2018. What is a Physician Home Champion? What skills does a home champion need to have?
HOME HEMODIALYSIS SYMPOSIUM ANNUAL DIALYSIS CONFERENCE 2018 HOW CAN WE FOSTER MORE PHYSICIAN CHAMPIONS? Joel D. Glickman, M.D. Director, Home Dialysis Programs Professor of Clinical Medicine University
More informationNATIONAL QUALITY FORUM Renal EM Submitted Measures
NATIONAL QUALITY FORUM Renal EM Submitted Measures Measure ID/ Title Measure Description Measure Steward Topic Area #1662 Percentage of patients aged 18 years and older with a diagnosis of CKD ACE/ARB
More informationInternationally, the arteriovenous fistula (AVF)
IN THE LITERATURE More Than Reducing Early Fistula Thrombosis Is Required: Lessons From the Dialysis Access Consortium Clopidogrel Fistula Study Commentary on Dember LM, Beck GJ, Allon M, et al: Effect
More informationMeasure #330: Adult Kidney Disease: Catheter Use for Greater Than or Equal to 90 Days National Quality Strategy Domain: Patient Safety
Measure #330: Adult Kidney Disease: Catheter Use for Greater Than or Equal to 90 Days National Quality Strategy Domain: Patient Safety 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES REGISTRY ONLY This is a
More informationCARE FOR CHRONIC RENAL PATIENTS ROLE OF MULTIDISCIPLINARY APPROACH ÁGNES HARIS MD PHD, ST. MARGIT HOSPITAL, BUDAPEST BUDAPEST NEPHROLOGY SCHOOL, 2017
CARE FOR CHRONIC RENAL PATIENTS ROLE OF MULTIDISCIPLINARY APPROACH ÁGNES HARIS MD PHD, ST. MARGIT HOSPITAL, BUDAPEST BUDAPEST NEPHROLOGY SCHOOL, 2017 RENEGOTIATING LIFE WITH CHRONIC KIDNEY DISEASE CONSTANTINI
More informationDedicated outpatient vascular access center decreases hospitalization and missed outpatient dialysis treatments
http://www.kidney-international.org & 2006 International Society of Nephrology original article Dedicated outpatient vascular access center decreases hospitalization and missed outpatient dialysis treatments
More informationThe Intact Nephron Hypothesis in Reverse: An Argument In Favor of Incremental Initiation Of Dialysis (With Residual Kidney Function)
The Intact Nephron Hypothesis in Reverse: An Argument In Favor of Incremental Initiation Of Dialysis (With Residual Kidney Function) Thomas A. Golper MD, FACP, FASN Vanderbilt University Medical Center
More informationNational Kidney and Urologic Diseases Information Clearinghouse (NKUDIC)
National Kidney and Urologic Diseases Information Clearinghouse (NKUDIC) A service of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH) Kidney
More informationCurrent treatment status and medical costs for hemodialysis vascular access based on analysis of the Korean Health Insurance Database
ORIGINAL ARTICLE Korean J Intern Med 218;33:116-1168 https://doi.org/1.394/kjim.218.17 Current treatment status and medical costs for hemodialysis vascular access based on analysis of the Korean Health
More informationFistula Maturation Failure. Successful AVF. ASDIN 2014 Scientific Meeting
Fistula First "Unassisted" evaluation of access dysfunction (eyes, ears, and fingers) Tushar Vachharajani, MD Chief, Nephrology Section W. G. (Bill) Hefner VAMC Salisbury, NC Quality improvement projects
More informationFocus su: Accessi Vascolari. dr Carlo Lomonte U.O.C. di Nefrologia e Dialisi Ente Ecclesiastico Ospedale Miulli Acquaviva delle Fonti - Ba
Focus su: Accessi Vascolari dr Carlo Lomonte U.O.C. di Nefrologia e Dialisi Ente Ecclesiastico Ospedale Miulli Acquaviva delle Fonti - Ba Sommario Epidemiologia dell Accesso Vascolare L Accesso Vascolare
More informationChapter 12. End Stage Kidney Disease in Indigenous Peoples of Australia and Aotearoa/New Zealand. ANZDATA Registry 39th Annual Report
Chapter 12 End Stage Kidney Disease in Indigenous Peoples of and Aotearoa/ 216 ANZDATA Registry 39th Annual Report Data to 31-Dec-215 Introduction In this chapter, the rates and practice patterns for end-stage
More informationObjectives. Peritoneal Dialysis vs. Hemodialysis 02/27/2018. Peritoneal Dialysis Prescription and Adequacy Monitoring
Peritoneal Dialysis Prescription and Adequacy Monitoring Christine B. Sethna, MD, EdM Division Director, Pediatric Nephrology Cohen Children s Medical Center Associate Professor Hofstra Northwell School
More informationVascular Access for Haemodialysis. Mike Stephens
Vascular Access for Haemodialysis Mike Stephens Overview Learning Objectives History and development of vascular access Standards in vascular access surgery Types of vascular access Complications Objectives
More informationINTEGRATED CARE. Table 1. RVCARE core components and goals. Figure 2. Patients who choose PD in the RVCARE Program
The first 120 days of crucial care: Strategies for managing incident dialysis patients Naveena Reddy, MS, RD Farzeen Sukheswalla, MS, RD George R. Aronoff, MD, MS, FACP. The Renal ACO New Approaches to
More informationNiagara Health Quality Coalition Employers Leading The Way In Health Care Quality
Niagara Health Quality Coalition Employers Leading The Way In Health Care Quality National Disease Management Summit Presented by: Bruce A. Boissonnault May 12, 2003 11:00 am to 12:00 pm Niagara Health
More informationPhysician Clinical Experiences with FIR Therapy in the UK and Taiwan
ENGLAND 1. Source: Moore I 1, Adam JH, Sweeney D, et al. (2011). Far infrared (FIR) therapy An effective treatment for AV fistula maturation and maintenance. J Am Soc Nephrol 2011; 22: 564A (Poster FR-PO1947).
More informationConversion of tunneled hemodialysis catheter consigned patients to arteriovenous fistula
Kidney International, Vol. 67 (2005), pp. 2399 2406 Conversion of tunneled hemodialysis catheter consigned patients to arteriovenous fistula ARIFASIF, GAUTAM CHERLA, DONNA MERRILL, CRISTIAN D. CIPLEU,
More informationUnderstanding Dialysis Facility Compare: Driving Informed Decision Making
Understanding Dialysis Facility Compare: Driving Informed Decision Making Elena K Balovlenkov Joel Andress Stephanie Glier Celeste Lee February 4, 2015 Overview Background Dialysis Facility Compare (DFC)
More informationHemodialysis arteriovenous fistula patency revisited; results of a prospective, multicenter initiative
Chapter 5 Hemodialysis arteriovenous fistula patency revisited; results of a prospective, multicenter initiative H.J.T.A.M. Huijbregts 1,2 M.L. Bots 3 C.H.A. Wittens 4 Y.C. Schrama 5 F.L. Moll 2 P.J. Blankestijn
More informationCost Analysis of the Creation and Maintenance of Functional Arteriovenous Grafts for Hemodialysis
Cost Analysis of the Creation and Maintenance of Functional Arteriovenous Grafts for Hemodialysis Neeraja Konuthula BS, Steven D. Abramowitz MD, Harry Schanzer MD, Peter L. Faries MD, Michael L. Marin
More informationREIMBURSEMENT AND ITS IMPACT ON YOUR DIALYSIS PROGRAM Tony Messana Executive Director Renal Services St. Joseph Hospital - Orange
REIMBURSEMENT AND ITS IMPACT ON YOUR DIALYSIS PROGRAM Tony Messana Executive Director Renal Services St. Joseph Hospital - Orange Agenda History of the Medicare ESRD Program Cost of Care for ESRD Patients
More informationmean hemoglobin 11 g/dl (110 g/l) compared to patients with lower mean hemoglobin values (Table 20).
S44 Figure 53 depicts the trend in Epoetin dosing from the 1998 study period to the 2003 study period, with an increasing mean weekly Epoetin dose (units/kg/wk) for patients prescribed Epoetin in lower
More informationChapter 25: Interactions of Dialysis Teams With Geriatricians
Chapter 25: Interactions of Dialysis Teams With Geriatricians Nicole Stankus* and Kellie Campbell *Section of Nephrology, University of Chicago, Chicago, Illinois; and Section of Geriatrics, University
More informationAcceptance onto dialysis guidelines: St George Hospital
Acceptance onto dialysis guidelines: St George Hospital The following information is a guideline to support clinicians in decision making regarding acceptance onto dialysis. A review of international guidelines
More informationDialysis outcomes: can we do better?
Dialysis outcomes: can we do better? Allan J. Collins, MD, FACP Professor of Medicine University of Minnesota Director, Chronic Disease Research Group Minneapolis Medical Research Foundation Director,
More information21th Budapest Nephrology School Ágnes Haris, Kálmán Polner
21th Budapest Nephrology School Ágnes Haris, Kálmán Polner 53 years old female, -worked as computer scientist, -lived with her husband and 2 children, -in excellent financial situation. Diagnosed with
More informationThe National Kidney Foundation expert panels
SPECIAL ARTICLE Balancing Fistula First With Catheters Last Eduardo Lacson Jr, MD, MPH, 1 J. Michael Lazarus, MD, 1 Jonathan Himmelfarb, MD, 2 T. Alp Ikizler, MD, 3 and Raymond M. Hakim, MD 1 The success
More informationTraining for Fluoroscopic Peritoneal Dialysis Catheter Placement. Rajeev Narayan MD San Antonio Kidney Disease Center San Antonio, TX
Training for Fluoroscopic Peritoneal Dialysis Catheter Placement Rajeev Narayan MD San Antonio Kidney Disease Center San Antonio, TX Disclosures No financial conflicts of interest to disclose. My comments
More informationCardiovascular Comorbidity and Late Referral Impact Arteriovenous Fistula Survival: A Prospective Multicenter Study
J Am Soc Nephrol 15: 204 209, 2004 Cardiovascular Comorbidity and Late Referral Impact Arteriovenous Fistula Survival: A Prospective Multicenter Study PIETRO RAVANI,* GIULIANO BRUNORI, SALVATORE MANDOLFO,
More informationEnd Stage Kidney Disease Among Indigenous Peoples of Australia and New Zealand
Chapter 12 End Stage Kidney Disease Among Indigenous Peoples of and New Zealand 216 ANZDATA Registry 39th Annual Report Data to 31-Dec-215 Introduction In this chapter, rates of end-stage kidney disease
More informationCOVERA Vascular Covered Stents in the Management of Dysfunctional AV Access
COVERA Vascular Covered Stents in the Management of Dysfunctional AV Access Bart L. Dolmatch, M.D., FSIR Palo Alto Medical Foundation Mountain View, CA USA This presentation is being made on behalf of
More informationPostoperative AV Fistula Evaluation. Postoperative examination protocol. Postoperative AVF Protocol. Hemodialysis Access Surveillance
Hemodialysis Access Surveillance Postoperative AV Fistula Evaluation Failure of maturation Stenosis Perigraft mass/fluid collection Joseph L. Mills, Sr., M.D. Professor of Surgery Chief, Division of Vascular
More informationDialysis Event Protocol
Dialysis Event Protocol Introduction In 2009, more than 370,000 patients were treated with maintenance hemodialysis in the United States. 1 Hemodialysis patients require a vascular access, which can be
More informationInterventions for AV-Shunt stenosis: What works best PTA, Stent or DCB?
Interventions for AV-Shunt stenosis: What works best PTA, Stent or DCB? Martin Forlee Vascular Surgeon Cape Town Disclosure Speaker name: Martin Forlee I have the following potential conflicts of interest
More informationAcute Start Dialysis: Navigating for our Patients
Acute Start Dialysis: Navigating for our Patients Innovative Nursing Roles Skipper: Mina Kashani RN(EC), MN, C Neph (C), S.S. St Michael s First Mate: Diane Watson, RN(EC), C Neph (C), S.S. Toronto General
More information( GFR 30 ml/min/1.73m 2 ) [2] (Tunneled cuffed catheter) [1] [3]
[1] 07-3422121-2045 E-mail: cyhsu@vghks.gov.tw ( GFR 30 ml/min/1.73m 2 ) [2] (fistula) (graft) (Tunneled cuffed catheter) [3] 97 20 2 63 Allen s test (Duplex doppler ultrasound) [4] 2.0 mm2.5 mm [5] ()
More informationNKF K/DOQI GUIDELINES
NKF K/DOQI GUIDELINES Executive Summaries Anemia Hemodialysis Peritoneal Dialysis Vascular Access Nutrition CKD 2002 Dyslipidemias Bone Metabolism Hypertension and Antihypertensive Agents Cardiovascular
More informationFOUR. Clinical Indicators of Care
Clinical Indicators of Care T FOUR The great questions of the time are not decided by speeches and majority decisions but by iron and blood. Otto von Bismarck, Speech to the Prussian Diet 78 ž 2000 ATLAS
More informationSupera for the Juxta-anastomotic AVF Stenosis
Supera for the Juxta-anastomotic AVF Stenosis Dr Shannon D. Thomas Vascular Access Surgeon Conjoint Senior Lecturer University of New South Wales Sydney, Australia Disclosure Speaker name: Dr S. D. Thomas...
More informationPercutaneous and Surgical Treatments
AVG Pseudoaneurysms Percutaneous and Surgical Treatments Marius Florescu M.D. Feb. 2015 ASDIN DEFINITION AVG Pseudoaneurysm Formation Incidence AVG Pseudoaneurysm incidence rate ranges between 2% and 10%
More informationMETABOLISM AND NUTRITION WITH PD OBESITY. Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle
METABOLISM AND NUTRITION WITH PD OBESITY Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle 1 Body Size in Patients New to Dialysis United States Body Mass Index, kg/m2 33 31
More informationThe Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009
The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009 Teresa Northcutt, RN BSN Primaris Program Manager, Prevention - CKD MO-09-01-CKD This material was prepared by Primaris,
More informationRuolo della clinica e del laboratorio nella diagnosi di malfunzionamento di una FAV
Ruolo della clinica e del laboratorio nella diagnosi di malfunzionamento di una FAV Carlo Basile Division of Nephrology and Dialysis Miulli General Hospital, Acquaviva delle Fonti, Italy VASCULAR ACCESS
More information2017 USRDS ANNUAL DATA REPORT KIDNEY DISEASE IN THE UNITED STATES S611
Healthy People 2020 In this chapter, we examine data for 11 Healthy People 2020 (HP2020) objectives 10 for CKD and one for diabetes spanning 20 total indicators for which the USRDS serves as the official
More information2006 NKF-DOQI Guidelines Preferred Vascular Access Order 1. Radiocephalic (wrist) fistula 2. Brachiocephalic (elbow) fistula 3. Basilic vein transposi
Stage 5 Chronic Kidney Disease Assessing the Results of AV Access: Realistic Outcomes in 2009 Sean P. Roddy, MD Albany, NY Defined as a GFR
More informationDisclaimer. PD Catheter Placement in Urgent and Emergent Peritoneal Dialysis. Catheter design and outcomes CATHETER DESIGN AND OUTCOME
ASDIN 2014 Scientific Meeting Disclaimer PD Catheter Placement in Urgent and Emergent Peritoneal Dialysis Bharat Sachdeva M.D. Associate Professor of Medicine/Nephrology Interventional Nephrology Division
More informationDepartment of Nephrology
OUTCOMES DIVISION OF MEDICINE Department of Nephrology About Cleveland Clinic Florida Cleveland Clinic Florida s medical staff are dedicated physicians who have joined the clinic as salaried doctors to
More informationPrimary Care Physicians and Clinicians. XXX on behalf of the Upper Midwest Fistula First Coalition. Chronic Kidney Disease (CKD) Resources
August 10, 2007 To: From: RE: Primary Care Physicians and Clinicians XXX on behalf of the Upper Midwest Fistula First Coalition Chronic Kidney Disease (CKD) Resources Caring for patients with chronic kidney
More informationJimmy Wei Hwa Tan, Surg, MD
Jimmy Wei Hwa Tan, Surg, MD Director, Department of Surgery Chief, Department of Cardiovascular Surgery Tainan An-Nan Municipal Hospital, China Medical University, Taiwan Disclosure I have the following
More information